![](/img/cover-not-exists.png)
PL02.03 Brigatinib vs Crizotinib in Patients With ALK Inhibitor-Naive Advanced ALK+ NSCLC: First Report of a Phase 3 Trial (ALTA-1L)
Camidge, R., Kim, H.R., Ahn, M., Yang, J.C., Han, J., Lee, J., Hochmair, M., Li, J.Y., Chang, G., Lee, K., Gridelli, C., Delmonte, A., Garcia Campelo, M.R., Kim, D., Bearz, A., Griesinger, F., MorabitVolume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.011
Date:
October, 2018
File:
PDF, 251 KB
english, 2018